Spectral Design & Test (SDT) demonstrates High-Capacity SRAM Memory Compilers targeted at advanced process nodes for AI driven edge Devices Medicenna Appoints Dr. John H. Sampson to its Board of Directors
Announces Results of Annual Meeting of Shareholders TORONTO and HOUSTON, Sept. 23, 2021 (GLOBE NEWSWIRE)…
vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results…
Ocugen, Inc. to Participate in Fireside Chat at the Cantor Virtual Global Healthcare Conference
MALVERN, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused…
IGM Biosciences to Present at the 2021 Cantor Virtual Global Healthcare Conference
MOUNTAIN VIEW, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a…
Entasis Therapeutics to Participate in the Cantor Fitzgerald Virtual Global Healthcare Conference
WALTHAM, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a…
Paratek Pharmaceuticals Presenting New Data for NUZYRA® (omadacycline) at IDWeek 2021
Key highlights include real-world health outcomes data for pneumonia and skin infections, data on in…
Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
SAN JOSE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics (Nasdaq: RANI), a clinical…
AGTC Provides Financial Results for the Fourth Quarter and Year Ended June 30, 2021
-Data from ongoing clinical trials in XLRP and ACHM shows evidence of clinical activity and…
SELLAS Life Sciences Announces Settlement of Derivative Litigation
NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.
DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ: SBBP) (the…
Viridian Therapeutics Announces Closing of Public Offering of Shares of Common Stock and Preferred Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
WALTHAM, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical…
SeqLL Announces Publication of a New Single-Cell Epitranscriptomic Method Powered by SeqLL’s tSMS® Platform
Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc. Funding for the…
New Expanded, Updated Edition of OnePoint Patient Care Clinical Symptom Guide Now Available
OPPC OPPC TEMPE, Ariz., Sept. 23, 2021 (GLOBE NEWSWIRE) — OnePoint Patient Care has published…
Medolife Rx Launches Ad Campaign With Tony Hawk, Sees Immediate Positive Results
BURBANK, CA, Sept. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated…
Alpha Cognition Announces Pricing of Public Offering
NOT FOR DISSEMINATION IN THE UNITED STATESOR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Sept….
Todos Medical Launches Tollovid Daily™ via Subscription at MyTollovid.com
Consumers can subscribe for an auto-shipped supply of Tollovid Daily™ 3CL protease inhibitor for immune…
SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections
Analysis of subpopulations from a total of 74 patients evaluated to date from FURI includes…
Surrozen Announces Appointment of Liz Nguyen as Vice President and Head of Human Resources
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Surrozen Inc. (Nasdaq: SRZN), a…
Scopus BioPharma to Present at the Benzinga Healthcare Small Cap Conference
Scopus to present on launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncology NEW YORK,…
Ayala Pharmaceuticals Announces Publication Highlighting Clinical Activity of its Gamma Secretase Inhibitor AL101 in Desmoid Tumors
REHOVOT, Israel and WILMINGTON, Del., Sept. 23, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (NASDAQ:…